# The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.

> **NCT02285634** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 68 (actual)

## Conditions studied

- Epistaxis
- Blood Pressure

## Interventions

- **DRUG:** Oxymetazoline 0.05%
- **DRUG:** Phenylephrine 0.25%
- **DRUG:** Lidocaine 1% plus epinephrine 1:100,000
- **DRUG:** Bacteriostatic 0.9% NaCL

## Key facts

- **NCT ID:** NCT02285634
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-12-22
- **Final completion:** 2017-12-22
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285634, "The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02285634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*